A Randomized Double Blind Controlled Trial Comparing Sugammadex and Neostigmine After Thoracic Anesthesia

NCT02256280 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

70

Enrollment

OTHER

Sponsor class

Stopped Low recruiting rate due to not activation of some collaborator centers

Conditions

Neuromuscular Blockade

Interventions

DRUG: Sugammadex
DRUG: Neostigmine

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano